9.450
+0,00%
2026-10-19
Fundamental Analysis
28 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -101.9% | -7.8% | 1 / 3 | +15.6% | -2.15 pp | -2.03 pp | +6.4% | 1.04 | 12.60 | 2.461 | +15,6% | −0,8 | −101,9% | 12.60 | 14.02 | −10,2% |
| Pts | 0 | 0 | 4 | 8 | 4 | 0 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 9.450 (close price on 2026-10-19)EPS (TTM): 750,2
Financial charts
1.Revenue & growth
VND bn2.461Q2/26
1.Revenue & growth
VND bn2.461Q2/26
2.Profit & growth
VND bn-0,82Q2/26
3.Profit mix (Penman)
VND bn56,6Q2/26
4.Margins & cost structure
%3.1%Q2/26
5.Returns & cash cycle
% · days1.2%Q2/26
6.Earnings quality & cash
VND bn181Q2/26
7.Asset structure
VND bn2.418Q2/26
8.Funding & debt health
VND bn · times2.418Q2/26
9.Revenue backlog
VND bn19,4Q2/26
10.Valuation
times · %13,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-14Q2/26
Adjusted EPS growth, latest quarter
-102%
Average adjusted EPS growth, 3 quarters
-102%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26